Defence And Security Tenders

Open House Drug Discount Agreements Rituximab, Atc L01fa01

Open House Drug Discount Agreements Trastuzumab, Atc L01fd01

Shelter storm protection in the Waldstadion

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Guselkumab (Exclusively in the Potency 100Mg), (Obo), Atc L04ac16 for the Period December 1St, 2024 - November 30Th, 2026

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Botulinum Toxin Type a (Obo), Atc M03ax21 for the Period December 1St, 2024 - November 30Th, 2026

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Glatiramer Acetate (Exclusively Pre-Filled Syringes), (Obo), Atc L03ax13 for the Period December 1St, 2024 - November 30Th...

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Cladribine (Obo), Atc L04aa40 for the Period December 1St, 2024 - November 30Th, 2026

Expansion and Renovation of Comenius Special School (53)

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Tobramycin (Excl. Hard Capsules with Powder for Inhalation), (Obo), Atc J01gb01 F. D. Z. 01.12.24-30.11.26

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Clomipramine (Obg), Atc N06aa04 for the Period December 1St, 2024 - November 30Th, 2026